Covidien gets tentative OK for generic imaging agent

02/27/2008 | Boston Globe (tiered subscription model), The

The FDA has given Covidien Ltd. tentative approval for marketing its Kit for the Preparation of Technetium Tc 99m Sestamibi Injection, a generic form of Cardiolite, Bristol-Myers Squibb Co.'s imaging agent. The product allows clinicians to monitor blood flow in the heart.

View Full Article in:

Boston Globe (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
Washington DC, DC
Director, Corporate Counsel
Tarrytown, NY